Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Thrombotic Thrombocytopenic Purpura
100%
Cardiovascular Complications
100%
In-hospital Mortality
36%
Acute Coronary Syndrome
27%
Heart Failure
18%
Plasmapheresis
18%
Cardiac Arrest
18%
Hospitalization
18%
Ventricular Arrhythmia
18%
Cardiogenic Shock
18%
Takotsubo Cardiomyopathy
18%
Atrioventricular Block
9%
Improved Outcomes
9%
Adult Patients
9%
Temporal Trends
9%
Arrhythmias Cardiac
9%
Age Groups
9%
Prognostic Implications
9%
Adjusted Odds Ratio
9%
Complication Rate
9%
Cardiac Conduction System
9%
Myocarditis
9%
Cardioembolic Stroke
9%
Tachyarrhythmia
9%
Age-stratified
9%
National Inpatient Sample
9%
Pericarditis
9%
Conduction System Disorder
9%
95% Confidence Interval
9%
Younger Age Group
9%
Atrial Arrhythmias
9%
Sex-stratified
9%
Myocarditis/pericarditis
9%
Medicine and Dentistry
Cardiovascular Disease
100%
Thrombotic Thrombocytopenic Purpura
100%
Hospital Mortality
36%
Acute Coronary Syndrome
27%
Apoplexy
18%
Congestive Heart Failure
18%
Age Groups
18%
Heart Arrest
18%
Cardiogenic Shock
18%
Takotsubo Cardiomyopathy
18%
Pericarditis
18%
Plasmapheresis
18%
Myocarditis
18%
Atrioventricular Block
9%
Cardiac Dysrhythmia
9%
Morbidity
9%
Tachyarrhythmia
9%
Arrhythmia
9%
Ventricular Tachycardia
9%
Conduction System of Heart
9%
Tachycardia
9%
Odds Ratio
9%
National Inpatient Sample
9%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombotic Thrombocytopenic Purpura
100%
Cardiovascular Disease
100%
Hospital Mortality
36%
Acute Coronary Syndrome
27%
Cerebrovascular Accident
18%
Heart Arrest
18%
Congestive Heart Failure
18%
Takotsubo Cardiomyopathy
18%
Myocarditis
18%
Cardiogenic Shock
18%
Pericarditis
18%
Morbidity
9%
Heart Arrhythmia
9%
Tachycardia
9%
Heart Ventricle Tachycardia
9%
Atrioventricular Block
9%